Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
RISPERDAL
Pharma
Amid flurry of settlements, J&J resolves Risperdal claims
J&J has settled roughly 9,000 liability claims in the U.S. surrounding its antipsychotic drug Risperdal for $800 million.
Kevin Dunleavy
Nov 1, 2021 10:45am
J&J scores as trial judge cuts $8B Risperdal verdict to $6.8M
Jan 21, 2020 10:39am
Appeals court upholds $70M Risperdal verdict against J&J
Nov 26, 2019 4:30pm
J&J's Risperdal caseload explodes with Pennsylvania ruling
Nov 21, 2019 10:42am
J&J, besieged by lawsuits, could be a steal for investors
Oct 11, 2019 10:38am
Jury hits J&J with $8B Risperdal verdict, but will it stand?
Oct 9, 2019 10:30am